An oral SARS-CoV-2 M <sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19

Authors: Dafydd R. Owen, Charlotte Allerton, Annaliesa S. Anderson, Lisa Aschenbrenner, Melissa Avery et al.

Year: 2021

PotencyOutbreakCoronavirus disease 2019 (COVID-19)In vivoVirology

1,863
Citations
2021
Published
10
Authors
Read PDFDOI